DOW

Dow shares rose 2.5% after Q3 earnings showed a margin recovery, with net sales of $11.27 billion and net income of $458 million. The lift reflects investors reacting to a cleaner earnings story amid a volatile chemicals cycle.

Dow’s Q3 2026 earnings beat expectations, driven by pricing actions and cost savings, and the company continues its long dividend record. The article suggests earnings exceeding forecasts may shift Dow’s investment narrative.

Dow reported Q3 earnings of $458 million on sales of $11.27 billion and declared a 35‑cent dividend, sparking a 12.8% one‑month share price gain. The piece notes the stock’s momentum despite a 21.3% decline in three‑year total shareholder return.

UBS analyst Joshua Spector keeps a Neutral stance on Dow and lifts the price target from $30 to $33.

After beating Q3 earnings and revenue estimates, Dow forecast $1.5 billion in Q4 EBITDA and analysts raised price targets, leading to a 3.3% rise in shares.

Citigroup analyst Patrick Cunningham maintains a Neutral view on Dow and raises the price target from $30 to $32.

The headline asks what Sherwin‑Williams offers that IFF does not, but no further details are provided.

The Nasdaq fell 2.6% as Meta’s higher capex floor revived doubts about AI spending, dragging chip stocks and hyperscalers lower. Lockheed Martin, Spotify and Procter & Gamble rallied, the 10-year yield dropped below 5%, and Brent oil climbed above $113.